937236-73-2 (ethyl 2-(2-chloropyridin-4-yl)acetate,ethyl 2-(2-chloro-4-pyridyl)acetate)

CAS号:
937236-73-2
中文名称:
ethyl 2-(2-chloropyridin-4-yl)acetate
英文名称:
ethyl 2-(2-chloro-4-pyridyl)acetate
分子式:
C9H10ClNO2
分子量:
199.634201526642

ethyl 2-(2-chloropyridin-4-yl)acetate(937236-73-2)名称与标识符

名称

中文别名:
2-(2-氯吡啶-4-基)乙酸乙酯;
英文别名:
ethyl 2-(2-chloropyridin-4-yl)acetate;MFDZGDBPQSJAIC-UHFFFAOYSA-N;NE34562;4-Pyridineacetic acid, 2-chloro-, ethyl ester;(2-chloro-pyridin-4-yl)-acetic acid ethyl ester;Ethyl 2-chloro-4-pyridineacetate (ACI);(2-Chloropyridin-4-yl)acetic acid ethyl ester;ethyl 2-(2-chloro-4-pyridyl)acetate;AKOS026729461;E81939;DB-334041;AS-83923;EN300-125107;SCHEMBL191331;CS-0148583;ethyl2-(2-chloropyridin-4-yl)acetate;937236-73-2;

标识符

InChIKey:
MFDZGDBPQSJAIC-UHFFFAOYSA-N
Inchi:
1S/C9H10ClNO2/c1-2-13-9(12)6-7-3-4-11-8(10)5-7/h3-5H,2,6H2,1H3
SMILES:
ClC1C=C(C=CN=1)CC(=O)OCC

ethyl 2-(2-chloropyridin-4-yl)acetate(937236-73-2)物化性质

实验特性

  • 沸点 : 287.3±25.0 °C at 760 mmHg
  • 闪点 : 227.2±28.7 °C
  • 颜色与性状 : NA
  • 密度 : 1.2±0.1 g/cm3

计算特性

  • 精确分子量 : 199.0400063g/mol
  • 氢键供体数量 : 0
  • 氢键受体数量 : 3
  • 可旋转化学键数量 : 4
  • 同位素质量 : 199.0400063g/mol
  • 重原子数量 : 13
  • 复杂度 : 175
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 0
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 2
  • 拓扑分子极性表面积 : 39.2

ethyl 2-(2-chloropyridin-4-yl)acetate(937236-73-2)国际标准相关数据

EINECS:
NA

ethyl 2-(2-chloropyridin-4-yl)acetate(937236-73-2)推荐厂家 更多厂家(11)

ethyl 2-(2-chloropyridin-4-yl)acetate(937236-73-2)合成路线

合成路线:1 步
反应条件:
参考文献:
Beta-lactamase inhibitors
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of [1,3]thiazolo[5,4-b]pyridine-2-amine derivatives as VEGF receptor 2 kinase inhibitors
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of heterocyclic compounds as glucokinase activators
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Prepartion of pyrimidines as ferroportin inhibitors
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Prepartion of cycloalka-fused pyrimidines as ferroportin inhibitors
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of pyrazolylurea compounds as hemopoietic cell kinase (p59-HCK) inhibitors for treatment of influenza infection
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Pyrazolylurea derivatives as antiviral agents and their preparation and use in the treatment of viral infection
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of pyrazolyl ureas as p38 MAP kinase inhibitors
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Quinolone derivatives, especially oxopyridopirimidines, as fibroblast growth factor inhibitors
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of 18F-labeled coumarin derivatives useful as in vivo imaging agent for MAO-B
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of heteroaryl antagonists of prostaglandin D2 receptors
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Spiro imidazole derivatives as PPAR modulators and their preparation, pharmaceutical compositions and use in the treatment of diseases associated with PPAR activity.
, World Intellectual Property Organization, , ,

ethyl 2-(2-chloropyridin-4-yl)acetate(937236-73-2)参考资料

Reaxys RN:
PubChem CID: